EUVIMEDEUVIMED entdecken
Open Access

Clinician Response to Pharmacogenetic Clinical Decision Support Alerts

Lauren K Lemke iD, Emily J Cicali iD, Roy Williams, Khoa A Nguyen, Larisa H Cavallari iD, Kristin Wiisanen

Clinical Pharmacology & Therapeutics · 2023-12 · 114 (6) · 1350-1357

DOI: 10.1002/cpt.3051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, online erschienen am 02.11.2023. Verfasst von Lauren K Lemke und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacotherapy and Translational Research, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Medical Order Entry Systems, Decision Support Systems, Clinical. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The objective of this study was to characterize clinician response following standardization of pharmacogenetic (PGx) clinical decision support alerts at University of Florida (UF) Health. A retrospective analysis of all PGx alerts that fired at a tertiary academic medical center from August 2020 through May 2022 was performed. Alert acceptance rate was calculated and compared across six gene–drug pairs, patient care setting, and clinician specialty. The disposition of the triggering medication was compared with the alert response and evaluated for congruence. There were a total of 818 alerts included for analysis of alert response, 557 alerts included in acceptance rate calculations, and 392 alerts with sufficient information to assess clinical response. The overall acceptance rate was 63%. The alert response and clinical response were congruent for 47% of alerts. Alert response was influenced by the triggering gene–drug pair, clinician specialty, patient care setting, and specialty of the provider who initially ordered the PGx test. Clinical response was mostly incongruent with alert response. Alert acceptance is influenced by the triggering gene–drug pair, clinician specialty, and care setting. Alert response is not a reliable surrogate marker for clinical action. Any future research into the impact of clinical decision support (CDS) alerts should focus on clinical response rather than alert response. Given the reliance on CDS alerts to enhance uptake of PGx, it is worthwhile to further investigate their impact on prescribing and patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medical Order Entry SystemsDecision Support Systems, ClinicalHumansPharmacogeneticsRetrospective StudiesElectronic Health Records

Autor:innen und Institutionen

  • Pharmacotherapy and Translational Research, University of Florida, Gainesville, Florida, USA.

ORCID-Profile: Lauren K Lemke, Emily J Cicali, Larisa H Cavallari

Förderung

  • NHGRI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Lemke, L. K., Cicali, E. J., Williams, R., Nguyen, K. A., Cavallari, L. H., & Wiisanen, K. (2023). Clinician Response to Pharmacogenetic Clinical Decision Support Alerts. Clinical Pharmacology & Therapeutics, 114(6), 1350-1357. https://doi.org/10.1002/cpt.3051

Vancouver

Lemke LK, Cicali EJ, Williams R, Nguyen KA, Cavallari LH, Wiisanen K. Clinician Response to Pharmacogenetic Clinical Decision Support Alerts. Clinical Pharmacology & Therapeutics. 2023;114(6):1350-1357. doi:10.1002/cpt.3051

BibTeX
@article{Lemke2023,
  author = {Lemke, Lauren K and Cicali, Emily J and Williams, Roy and Nguyen, Khoa A and Cavallari, Larisa H and Wiisanen, Kristin},
  title = {Clinician Response to Pharmacogenetic Clinical Decision Support Alerts},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2023},
  volume = {114},
  number = {6},
  pages = {1350--1357},
  doi = {10.1002/cpt.3051}
}
Kostenlos starten →